ASPI
ASPI
NASDAQ · Chemicals

Asp Isotopes Inc

$4.80
-0.24 (-4.76%)
Financial Highlights (FY 2026)
Revenue
9.42M
Net Income
-73,537,006
Gross Margin
38.6%
Profit Margin
-780.2%
Rev Growth
D/E Ratio
0.76
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.6% 49.6% 49.6% 49.6%
Operating Margin -635.9% 13.8% 13.1% 12.1%
Profit Margin -780.2% 12.6% 12.3% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.42M 298.65M 269.30M 325.87M
Gross Profit 3.64M 148.12M 133.56M 161.62M
Operating Income -59,902,906 41.26M 35.28M 39.45M
Net Income -73,537,006 37.50M 33.23M 37.34M
Gross Margin 38.6% 49.6% 49.6% 49.6%
Operating Margin -635.9% 13.8% 13.1% 12.1%
Profit Margin -780.2% 12.6% 12.3% 11.5%
Rev Growth +3.5% +12.0% -0.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 148.11M 381.61M 393.52M 387.27M
Total Equity 194.38M 391.62M 358.89M 384.20M
D/E Ratio 0.76 0.97 1.10 1.01
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -59,166,396 50.27M 50.15M 56.13M
Free Cash Flow 41.53M 25.63M 31.06M